Logo image of IFOS.CA

ITAFOS INC (IFOS.CA) Stock Fundamental Analysis

TSX-V:IFOS - TSX Venture Exchange - KYG497151087 - Common Stock - Currency: CAD

2.97  +0.01 (+0.34%)

Fundamental Rating

6

Taking everything into account, IFOS scores 6 out of 10 in our fundamental rating. IFOS was compared to 29 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making IFOS a very profitable company, without any liquidiy or solvency issues. IFOS has a bad growth rate and is valued cheaply. These ratings would make IFOS suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year IFOS was profitable.
IFOS had a positive operating cash flow in the past year.
Of the past 5 years IFOS 4 years were profitable.
IFOS had a positive operating cash flow in 4 of the past 5 years.
IFOS.CA Yearly Net Income VS EBIT VS OCF VS FCFIFOS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

IFOS's Return On Assets of 13.53% is amongst the best of the industry. IFOS outperforms 100.00% of its industry peers.
IFOS has a better Return On Equity (26.45%) than 100.00% of its industry peers.
IFOS's Return On Invested Capital of 13.69% is amongst the best of the industry. IFOS outperforms 86.21% of its industry peers.
IFOS had an Average Return On Invested Capital over the past 3 years of 19.10%. This is significantly above the industry average of 7.51%.
The last Return On Invested Capital (13.69%) for IFOS is well below the 3 year average (19.10%), which needs to be investigated, but indicates that IFOS had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.53%
ROE 26.45%
ROIC 13.69%
ROA(3y)10.67%
ROA(5y)5.37%
ROE(3y)24.11%
ROE(5y)6.67%
ROIC(3y)19.1%
ROIC(5y)N/A
IFOS.CA Yearly ROA, ROE, ROICIFOS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Profit Margin, with a value of 20.03%, IFOS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
IFOS's Profit Margin has improved in the last couple of years.
The Operating Margin of IFOS (23.05%) is better than 96.55% of its industry peers.
In the last couple of years the Operating Margin of IFOS has declined.
IFOS has a Gross Margin of 28.74%. This is amongst the best in the industry. IFOS outperforms 89.66% of its industry peers.
IFOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.05%
PM (TTM) 20.03%
GM 28.74%
OM growth 3Y-2.98%
OM growth 5YN/A
PM growth 3Y13.11%
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
IFOS.CA Yearly Profit, Operating, Gross MarginsIFOS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

7

2. Health

2.1 Basic Checks

IFOS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, IFOS has more shares outstanding
The number of shares outstanding for IFOS has been increased compared to 5 years ago.
The debt/assets ratio for IFOS has been reduced compared to a year ago.
IFOS.CA Yearly Shares OutstandingIFOS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
IFOS.CA Yearly Total Debt VS Total AssetsIFOS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

IFOS has an Altman-Z score of 1.40. This is a bad value and indicates that IFOS is not financially healthy and even has some risk of bankruptcy.
IFOS's Altman-Z score of 1.40 is in line compared to the rest of the industry. IFOS outperforms 55.17% of its industry peers.
The Debt to FCF ratio of IFOS is 1.63, which is an excellent value as it means it would take IFOS, only 1.63 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IFOS (1.63) is better than 100.00% of its industry peers.
IFOS has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
IFOS's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. IFOS outperforms 75.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.63
Altman-Z 1.4
ROIC/WACC1.5
WACC9.13%
IFOS.CA Yearly LT Debt VS Equity VS FCFIFOS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

IFOS has a Current Ratio of 3.20. This indicates that IFOS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IFOS (3.20) is better than 89.66% of its industry peers.
A Quick Ratio of 1.72 indicates that IFOS should not have too much problems paying its short term obligations.
The Quick ratio of IFOS (1.72) is better than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 1.72
IFOS.CA Yearly Current Assets VS Current LiabilitesIFOS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. Growth

3.1 Past

The earnings per share for IFOS have decreased by -1.42% in the last year.
Measured over the past years, IFOS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.06% on average per year.
The Revenue has been growing slightly by 5.52% in the past year.
The Revenue has been growing slightly by 7.67% on average over the past years.
EPS 1Y (TTM)-1.42%
EPS 3Y16.06%
EPS 5YN/A
EPS Q2Q%-66.47%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y5.93%
Revenue growth 5Y7.67%
Sales Q2Q%52.17%

3.2 Future

IFOS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.66% yearly.
IFOS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.04% yearly.
EPS Next Y-50.45%
EPS Next 2Y-25.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.06%
Revenue Next 2Y-1.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IFOS.CA Yearly Revenue VS EstimatesIFOS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
IFOS.CA Yearly EPS VS EstimatesIFOS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8 -10

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.21, the valuation of IFOS can be described as very cheap.
IFOS's Price/Earnings ratio is rather cheap when compared to the industry. IFOS is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.50. IFOS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.39, which indicates a rather cheap valuation of IFOS.
Based on the Price/Forward Earnings ratio, IFOS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
IFOS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 5.21
Fwd PE 7.39
IFOS.CA Price Earnings VS Forward Price EarningsIFOS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IFOS indicates a rather cheap valuation: IFOS is cheaper than 100.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IFOS is valued cheaper than 96.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.87
EV/EBITDA 2.65
IFOS.CA Per share dataIFOS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

IFOS has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as IFOS's earnings are expected to decrease with -25.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.66%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

IFOS has a Yearly Dividend Yield of 2.31%.
Compared to an average industry Dividend Yield of 5.94, IFOS pays a bit more dividend than its industry peers.
IFOS's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

IFOS does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IFOS.CA Yearly Dividends per shareIFOS.CA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y-25.66%
EPS Next 3YN/A
IFOS.CA Yearly Income VS Free CF VS DividendIFOS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

ITAFOS INC

TSX-V:IFOS (7/18/2025, 7:00:00 PM)

2.97

+0.01 (+0.34%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06
Inst Owners0.4%
Inst Owner ChangeN/A
Ins Owners1.43%
Ins Owner ChangeN/A
Market Cap554.83M
Analysts84
Price Target4.34 (46.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date04-09 2025-04-09 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.78%
Min EPS beat(2)-29.46%
Max EPS beat(2)35.01%
EPS beat(4)3
Avg EPS beat(4)38.02%
Min EPS beat(4)-29.46%
Max EPS beat(4)98.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)23.91%
Min Revenue beat(2)-2.19%
Max Revenue beat(2)50.02%
Revenue beat(4)3
Avg Revenue beat(4)30.41%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)68.54%
Revenue beat(8)7
Avg Revenue beat(8)23.42%
Revenue beat(12)9
Avg Revenue beat(12)15.03%
Revenue beat(16)11
Avg Revenue beat(16)11.9%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 5.21
Fwd PE 7.39
P/S 0.81
P/FCF 6.87
P/OCF 3.11
P/B 1.07
P/tB 1.07
EV/EBITDA 2.65
EPS(TTM)0.57
EY19.19%
EPS(NY)0.4
Fwd EY13.53%
FCF(TTM)0.43
FCFY14.56%
OCF(TTM)0.95
OCFY32.15%
SpS3.66
BVpS2.77
TBVpS2.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.53%
ROE 26.45%
ROCE 17.75%
ROIC 13.69%
ROICexc 16.2%
ROICexgc 16.2%
OM 23.05%
PM (TTM) 20.03%
GM 28.74%
FCFM 11.8%
ROA(3y)10.67%
ROA(5y)5.37%
ROE(3y)24.11%
ROE(5y)6.67%
ROIC(3y)19.1%
ROIC(5y)N/A
ROICexc(3y)20.96%
ROICexc(5y)N/A
ROICexgc(3y)20.96%
ROICexgc(5y)N/A
ROCE(3y)24.77%
ROCE(5y)N/A
ROICexcg growth 3Y-1.19%
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.19%
ROICexc growth 5YN/A
OM growth 3Y-2.98%
OM growth 5YN/A
PM growth 3Y13.11%
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.63
Debt/EBITDA 0.56
Cap/Depr 198.75%
Cap/Sales 14.26%
Interest Coverage 13.13
Cash Conversion 86.22%
Profit Quality 58.91%
Current Ratio 3.2
Quick Ratio 1.72
Altman-Z 1.4
F-Score6
WACC9.13%
ROIC/WACC1.5
Cap/Depr(3y)154.24%
Cap/Depr(5y)126.08%
Cap/Sales(3y)10.69%
Cap/Sales(5y)9.14%
Profit Quality(3y)413.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.42%
EPS 3Y16.06%
EPS 5YN/A
EPS Q2Q%-66.47%
EPS Next Y-50.45%
EPS Next 2Y-25.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.52%
Revenue growth 3Y5.93%
Revenue growth 5Y7.67%
Sales Q2Q%52.17%
Revenue Next Year1.06%
Revenue Next 2Y-1.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.01%
EBIT growth 3Y2.77%
EBIT growth 5YN/A
EBIT Next Year-16.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.29%
FCF growth 3Y-4.54%
FCF growth 5YN/A
OCF growth 1Y-25.33%
OCF growth 3Y8.3%
OCF growth 5Y27.93%